Laufs U - Search Results

1

Effects of endurance training on serum lipids.

Fikenzer K, Fikenzer S, Laufs U, Werner C. Fikenzer K, et al. Among authors: laufs u. Vascul Pharmacol. 2018 Feb;101:9-20. doi: 10.1016/j.vph.2017.11.005. Epub 2017 Dec 1. Vascul Pharmacol. 2018. PMID: 29203287 Review.

2

The PPAR-gamma agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells.

Gensch C, Clever YP, Werner C, Hanhoun M, Böhm M, Laufs U. Gensch C, et al. Among authors: laufs u. Atherosclerosis. 2007 May;192(1):67-74. doi: 10.1016/j.atherosclerosis.2006.06.026. Epub 2006 Jul 28. Atherosclerosis. 2007. PMID: 16876172

3

Regulation of endothelial progenitor cells by prostaglandin E1 via inhibition of apoptosis.

Gensch C, Clever Y, Werner C, Hanhoun M, Böhm M, Laufs U. Gensch C, et al. Among authors: laufs u. J Mol Cell Cardiol. 2007 Mar;42(3):670-7. doi: 10.1016/j.yjmcc.2006.12.017. Epub 2007 Jan 9. J Mol Cell Cardiol. 2007. PMID: 17291526

4

The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance.

Werner C, Kamani CH, Gensch C, Böhm M, Laufs U. Werner C, et al. Among authors: laufs u. Diabetes. 2007 Oct;56(10):2609-15. doi: 10.2337/db07-0069. Epub 2007 Jul 10. Diabetes. 2007. PMID: 17623816 Clinical Trial.

5

Effects of physical exercise on myocardial telomere-regulating proteins, survival pathways, and apoptosis.

Werner C, Hanhoun M, Widmann T, Kazakov A, Semenov A, Pöss J, Bauersachs J, Thum T, Pfreundschuh M, Müller P, Haendeler J, Böhm M, Laufs U. Werner C, et al. Among authors: laufs u. J Am Coll Cardiol. 2008 Aug 5;52(6):470-82. doi: 10.1016/j.jacc.2008.04.034. J Am Coll Cardiol. 2008. PMID: 18672169 Free article.

6

Physical exercise prevents cellular senescence in circulating leukocytes and in the vessel wall.

Werner C, Fürster T, Widmann T, Pöss J, Roggia C, Hanhoun M, Scharhag J, Büchner N, Meyer T, Kindermann W, Haendeler J, Böhm M, Laufs U. Werner C, et al. Among authors: laufs u. Circulation. 2009 Dec 15;120(24):2438-47. doi: 10.1161/CIRCULATIONAHA.109.861005. Circulation. 2009. PMID: 19948976

7

Integrin-linked kinase is a central mediator in angiotensin II type 1- and chemokine receptor CXCR4 signaling in myocardial hypertrophy.

Bettink SI, Werner C, Chen CH, Müller P, Schirmer SH, Walenta KL, Böhm M, Laufs U, Friedrich EB. Bettink SI, et al. Among authors: laufs u. Biochem Biophys Res Commun. 2010 Jun 25;397(2):208-13. doi: 10.1016/j.bbrc.2010.05.086. Epub 2010 May 20. Biochem Biophys Res Commun. 2010. PMID: 20493167

8

The renin inhibitor aliskiren upregulates pro-angiogenic cells and reduces atherogenesis in mice.

Pöss J, Werner C, Lorenz D, Gensch C, Böhm M, Laufs U. Pöss J, et al. Among authors: laufs u. Basic Res Cardiol. 2010 Nov;105(6):725-35. doi: 10.1007/s00395-010-0120-5. Epub 2010 Sep 21. Basic Res Cardiol. 2010. PMID: 20857126

9

Pioglitazone activates aortic telomerase and prevents stress-induced endothelial apoptosis.

Werner C, Gensch C, Pöss J, Haendeler J, Böhm M, Laufs U. Werner C, et al. Among authors: laufs u. Atherosclerosis. 2011 May;216(1):23-34. doi: 10.1016/j.atherosclerosis.2011.02.011. Epub 2011 Feb 17. Atherosclerosis. 2011. PMID: 21396644

10

Cardiovascular disease and dyslipidemia: beyond LDL.

Pöss J, Custodis F, Werner C, Weingärtner O, Böhm M, Laufs U. Pöss J, et al. Among authors: laufs u. Curr Pharm Des. 2011;17(9):861-70. doi: 10.2174/138161211795428858. Curr Pharm Des. 2011. PMID: 21418031 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

572 results

Search Page